These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 26189506)

  • 1. Effects of add-on tipepidine on treatment-resistant depression: an open-label pilot trial.
    Shirayama Y; Suzuki M; Takahashi M; Sato K; Hashimoto K
    Acta Neuropsychiatr; 2016 Feb; 28(1):51-4. PubMed ID: 26189506
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The centrally acting non-narcotic antitussive tipepidine produces antidepressant-like effect in the forced swimming test in rats.
    Kawaura K; Ogata Y; Inoue M; Honda S; Soeda F; Shirasaki T; Takahama K
    Behav Brain Res; 2009 Dec; 205(1):315-8. PubMed ID: 19616036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tipepidine, a non-narcotic antitussive, exerts an antidepressant-like effect in the forced swimming test in adrenocorticotropic hormone-treated rats.
    Kawaura K; Ogata Y; Honda S; Soeda F; Shirasaki T; Takahama K
    Behav Brain Res; 2016 Apr; 302():269-78. PubMed ID: 26738969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological mechanisms of antidepressant-like effect of tipepidine in the forced swimming test.
    Kawaura K; Miki R; Urashima Y; Kawahara R; Soeda F; Shirasaki T; Takahama K
    Behav Brain Res; 2012 Jan; 226(2):381-5. PubMed ID: 21995940
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of tipepidine with novel antidepressant-like action on c-fos-like protein expression in rat brain.
    Kawahara R; Soeda F; Kawaura K; Honda S; Miki R; Noguchi T; Shirasaki T; Takahama K
    Brain Res; 2013 Jun; 1513():135-42. PubMed ID: 23548603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between plasma concentrations of lamotrigine and its early therapeutic effect of lamotrigine augmentation therapy in treatment-resistant depressive disorder.
    Kagawa S; Mihara K; Nakamura A; Nemoto K; Suzuki T; Nagai G; Kondo T
    Ther Drug Monit; 2014 Dec; 36(6):730-3. PubMed ID: 24819973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tipepidine increases dopamine level in the nucleus accumbens without methamphetamine-like behavioral sensitization.
    Hamao K; Kawaura K; Soeda F; Hamasaki R; Shirasaki T; Takahama K
    Behav Brain Res; 2015 May; 284():118-24. PubMed ID: 25687844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potent inhibitory effect of tipepidine on marble-burying behavior in mice.
    Honda S; Kawaura K; Soeda F; Shirasaki T; Takahama K
    Behav Brain Res; 2011 Jan; 216(1):308-12. PubMed ID: 20713091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tipepidine enhances the antinociceptive-like action of carbamazepine in the acetic acid writhing test.
    Kawaura K; Miki R; Urashima Y; Honda S; Shehata AM; Soeda F; Shirasaki T; Takahama K
    Eur J Pharmacol; 2011 Jan; 651(1-3):106-8. PubMed ID: 21114989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral ketamine augmentation for chronic suicidality in treatment-resistant depression.
    De Gioannis A; De Leo D
    Aust N Z J Psychiatry; 2014 Jul; 48(7):686. PubMed ID: 24452289
    [No Abstract]   [Full Text] [Related]  

  • 11. A double-blind placebo-controlled trial of lamotrigine as an antidepressant augmentation agent in treatment-refractory unipolar depression.
    Barbee JG; Thompson TR; Jamhour NJ; Stewart JW; Conrad EJ; Reimherr FW; Thompson PM; Shelton RC
    J Clin Psychiatry; 2011 Oct; 72(10):1405-12. PubMed ID: 21367355
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-frequency rTMS over right dorsolateral prefrontal cortex in the treatment of resistant depression: cognitive improvement is independent from clinical response, resting motor threshold is related to clinical response.
    Pallanti S; Di Rollo A; Antonini S; Cauli G; Hollander E; Quercioli L
    Neuropsychobiology; 2012 Jun; 65(4):227-35. PubMed ID: 22653158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of non-suppression of cortisol levels in a patient with refractory depression receiving ketamine.
    Ostroff R; Kothari JS
    Am J Psychiatry; 2015 Jan; 172(1):95-6. PubMed ID: 25553498
    [No Abstract]   [Full Text] [Related]  

  • 14. Electroconvulsive therapy and cognitive functions in treatment-resistant depression.
    Bodnar A; Krzywotulski M; Lewandowska A; Chlopocka-Wozniak M; Bartkowska-Sniatkowska A; Michalak M; Rybakowski JK
    World J Biol Psychiatry; 2016; 17(2):159-64. PubMed ID: 26482837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lithium versus lamotrigine augmentation in treatment resistant unipolar depression: a randomized, open-label study.
    Schindler F; Anghelescu IG
    Int Clin Psychopharmacol; 2007 May; 22(3):179-82. PubMed ID: 17414745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma dehydroepiandrosterone sulfate in unipolar major depression. Short communication.
    Takebayashi M; Kagaya A; Uchitomi Y; Kugaya A; Muraoka M; Yokota N; Horiguchi J; Yamawaki S
    J Neural Transm (Vienna); 1998; 105(4-5):537-42. PubMed ID: 9720981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effectiveness and safety of adjunctive aripiprazole in Taiwanese patients with antidepressant-refractory major depressive disorder: a prospective, open-label trial.
    Chen SJ; Hsiao YL; Shen TW; Chen ST
    J Clin Psychopharmacol; 2012 Feb; 32(1):56-60. PubMed ID: 22198444
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidepressant-like effect of centrally acting non-narcotic antitussive caramiphen in a forced swimming test.
    Kawaura K; Miki R; Shima E; Honda S; Soeda F; Shirasaki T; Takahama K
    Neurosci Lett; 2010 Sep; 481(3):188-90. PubMed ID: 20621160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olanzapine augmentation of milnacipran for stage 2 treatment-resistant major depression: an open study.
    Boku S; Inoue T; Honma H; Honma H; Nakagawa S; Koyama T
    Hum Psychopharmacol; 2011 Apr; 26(3):237-41. PubMed ID: 21638328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain-derived neurotrophic factor serum concentrations in acute depressive patients increase during lithium augmentation of antidepressants.
    Ricken R; Adli M; Lange C; Krusche E; Stamm TJ; Gaus S; Koehler S; Nase S; Bschor T; Richter C; Steinacher B; Heinz A; Rapp MA; Borgwardt S; Hellweg R; Lang UE
    J Clin Psychopharmacol; 2013 Dec; 33(6):806-9. PubMed ID: 24018547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.